Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cellsAmanda van Vliet, Anna‐Maria Georgoudaki, Susan Gibbs et al.|iScience|2023Cited by 9
Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activityAmanda van Vliet, Monica Raimo, Mirjam G.C.N. van den Hout et al.|Molecular Therapy Oncology|2024Cited by 9
Interlaboratory assessment of candidate reference materials for lentiviral vector copy number and integration site measurementsHua‐Jun He, Sheng Lin‐Gibson, Zhiyong He et al.|Molecular Therapy — Methods & Clinical Development|2025Cited by 3
245 Cord blood CD34<sup>+</sup> stem cells are efficiently transduced with anti-CD19-CAR and expanded and differentiated into viveNK™ natural killer cells which display selective cytotoxicity against B-cell leukemiaMonica Raimo, Adil Deniz Duru, Nina Lamers-Kok et al.|Regular and Young Investigator Award Abstracts|2022Cited by 0
384 Single-cell transcriptomics, proteomics and in vitro cytotoxicity of allogeneic cryopreserved natural killer cell therapy GTA002 identify potent effector signaturesMonica Raimo, Jan Spanholtz, Amanda van Vliet et al.|Regular and Young Investigator Award Abstracts|2023Cited by 0